Corporate Banner
Satellite Banner
Immunology
Scientific Community
 
Join | Sign in
Home>News>This Article
  News
Return

Apeiron and Rentschler Announces Partnership Agreement

Published: Friday, August 02, 2013
Last Updated: Friday, August 02, 2013
Bookmark and Share
Rentschler produces Apeiron's monoclonal antibody APN311 for late stage clinical development and market.


Access to this article and other content is for registered users.

Join the Technology Networks Community

  • Access to the latest scientific news, products and research through Technology Networks
  • Upload and share your posters on ePosters
  • View a library of 1,800+ scientific and medical posters
  • A library of 3,000+ scientific videos on LabTube


Sign In



Forgotten your details? Click Here
If you already have an account with Technology Networks, please use your existing login details. If you do not yet have an account please join here.

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
Freshly Squeezed Vaccines
Microfluidic cell-squeezing device opens new possibilities for cell-based vaccines.
New Target for Treating Rheumatoid Arthritis
Many affected individuals still suffer with progressive joint damage, despite treatment. This study has discovered a new treatment target which could open a door to preventing this ongoing damage.
Shining A New Light On The Immune System
Scientists at the University of St Andrews have developed a revolutionary method of identifying cells of the immune system with “molecular fingerprints” which could pave the way for the rapid detection of conditions such as leukaemia and lymphoma from a small blood sample.
Promising Malaria and Dengue Vaccines Will Not Defeat Diseases
Although vaccination is a key part of the control of disease GlobalData stress the importance of a multi-dimensional approach.
'Redesigned' Antibodies May Neutralize HIV
With the help of a new computer program researchers have made structural alterations to an antibody, increasing its ability to tackle the AIDS virus.
How Early Childhood Vaccination Reduces Leukemia Risk
Chronic infections push ‘pre-leukemia’ cells, common in newborns, into malignancy.
Novel Class Of Antimicrobials Kills Multidrug Resistant-Tuberculosis
Researchers hope that they can end the global TB crisis by utilizing a novel bactericidal mechasnism.
Inflammation Stops The Clock
Researchers at Trinity College Dublin and the University of Pennsylvania have uncovered an important link between our body clock and the immune system that will have relevance to the treatment of inflammatory and infectious diseases.
Designing Better Medical Implants
A team of MIT researchers have discovered a novel method for reducing the typical immune system rejection response when implanting biomedical devices into the body.
Finding Should Enhance Treatments that Stop Immune System Attacks
Research published in the journal Immunity describes how regulatory T cells can cure inflammatory disease.
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters